Showing all 2 results
-
L_13 GI Effects Comprehensive Profile – Stool
£925.00 More InfoAdd to cartThe biomarkers from the GI Effects Comprehensive Profile are reported using the DIG framework, providing key clinical information for three main gastrointestinal functional areas.
-
L_31 Small Intestinal Bacterial Overgrowth (SIBO)
£565.00 More InfoAdd to cartIn general, clinical management of the SIBO patient involves antimicrobial therapy, prokinetic agents, nutrient supplementation, dietary interventions, and treatment of comorbid conditions.
